SXTP 1.41 ▼ -4.73% Live Trading Data - Stocknear

60 Degrees Pharmaceutical...

NASDAQ: SXTP · Real-Time Price · USD
1.41
-0.07 (-4.73%)
At close: Sep 05, 2025, 3:46 PM
1.28
-9.22%
After-hours: Sep 05, 2025, 07:42 PM EDT
-4.73%
Bid 1.37
Market Cap 4.55M
Revenue (ttm) 960.89K
Net Income (ttm) -7.8M
EPS (ttm) 0.07
PE Ratio (ttm) 20.14
Forward PE -0.28
Analyst Hold
Ask 1.45
Volume 39,673
Avg. Volume (20D) 573,616
Open 1.45
Previous Close 1.48
Day's Range 1.41 - 1.45
52-Week Range 1.22 - 12.45
Beta 2.73

About SXTP

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol SXTP
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for SXTP stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Next Earnings Release

60 Degrees Pharmaceuticals Inc. is scheduled to release its earnings on Nov 13, 2025, during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
-19.35%
60 Degrees Pharmaceuticals shares are trading lowe... Unlock content with Pro Subscription
1 month ago
-13.89%
SXTP stock has given up its prior gain. 60 Degrees Pharmaceuticals shares were trading higher after the company announced it will conduct a gap analysis of its existing data prior to submitting a Minor Use Minor Species designation request to the FDA for tafenoquine for the treatment of acute canine babesiosis.